Press Releases

DURHAM, N.C., Jan. 10, 2020 /PRNewswire/ -- Biomarck Pharmaceuticals, Ltd today announced that it is delighted to have been invited to present Phase 2 clinical data from its study in NSCLC and an update on the Phase 2 study in ARDS at the JPM conference.These two controlled clinical studies add to the breadth of clinical data observed in over 300 patients dosed wi

Read more...

SAN DIEGO, Jan. 10, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Dermira, Inc. (NASDAQ: DERM) ("Dermira") breached their fiduciary duties in connection with the proposed sale of the Company to Eli Lilly and Company ("Lilly").On January 10, 2020, De

Read more...

ATLANTA, Jan. 10, 2020 /PRNewswire/ -- The Prevention Services Clearinghouse, developed in conjunction with the Family First Prevention Services Act ("FFPSA"), was created to review research evidence on programs designed to improve services to children and families and prevent foster care placements. MST received the top rating, 'well supported,' by the Clearinghous

Read more...

WAYNE, Pa., Jan. 10, 2020 /PRNewswire/ -- The Columbus Organization, a leading provider of case management services for individuals with Intellectual and Developmental Disabilities, recently announced several key investments in the Company's infrastructure to accommodate the rapid growth of the Company.  "We continue to make investments in The Columbus O

Read more...

PHILADELPHIA, Jan. 10, 2020 /PRNewswire/ -- vybe urgent care, the leading independent operator of urgent care centers in the Greater Philadelphia area, announces the opening of a new center in Center City East at 618 Market Street, Philadelphia, PA 19106.  The center will be open beginning

Read more...

BURLINGAME, Calif., Jan. 10, 2020 /PRNewswire/ -- Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, today announced a

Read more...

NEEDHAM, Mass., Jan. 10, 2020 /PRNewswire/ -- Candel Therapeutics, a leader in developing viral immunotherapies across multiple tumor indications, announced today the appointment of Sandra E. Poole as Chief Operating Officer.  "I am thrilled to welcome Sandra to Candel and work with her to drive the full potential of our ne

Read more...

NEW YORK, Jan. 10, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Maged Shenouda has been appointed the Company's new Chief Financial Officer (CFO).  Mr. Shenouda, who has nearly 30

Read more...

GOLETA, Calif., Jan. 10, 2020 /PRNewswire/ -- Serimmune, a leader in understanding the functional antibody repertoire's role in human disease, announced today that they have entered into an agreement

Read more...

NEW ORLEANS, Jan. 10, 2020 /PRNewswire/ -- LongueVue Capital Partners ("LVC"), a partnership-driven, operator-centric private equity firm based in New Orleans with approximately $500 million of assets under management, announced today that Geoff Glass and

Read more...